Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
A new study, published in Cell Metabolism, suggests that targeting the gut microbiota could help to treat memory impairment, in particular in obese people.
Some studies have underlined some differences in the gut microbial composition of people with anorexia and healthy individuals.
A new study published in Nature claims that specific bacteria that live in a mother’s gut produce molecules that influence the wiring of the fetal brain.
In a Perspective published in Science, surgeon-scientist Jennifer Wargo explores recent advances in modulating the microbial community within the human gut.
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
A new study published in Cell suggests that the gut microbiota of infants born by C-section can be restored by transferring fecal microbiota from their mothers.
Strains of a particular microbe could boost the production of GABA—a neurotransmitter that plays a key role in anxiety and depression disorders.
Researchers have found that disrupting the microbiota-gut axis by altering circadian rhythms or diet can drive Crohn-like inflammation of the intestine in mice.
A gut microbiota-modulated neural pathway can regulate blood sugar independently from the central nervous system, a new study pubblished in Science claims.
Fecal microbial transplant could be a promising treatment for intestinal graft-versus-host disease caused by stem cell transplantation.
